Atara Biotherapeutics, Inc.
USD11.17
+0.66 (+6.28%)
CEO
Anhco Nguyen
IPO Date
2014-10-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.60
Prev. Close
$10.51
Day Low
$10.47
Day High
$11.18
52W Low
$3.92
52W High
$19.14
Market Cap
$0.10B
Volume
0.06M
| -1.2 |
| 31 Dec 2023 | FY | -3.7% | -3220.9% | 278.3% | -166.8% | -0.58 | 0.72 | -0.2 |
| 31 Dec 2022 | FY | 100.0% | -359.1% | -180.3% | -60.7% | 0.57 | 3.74 | -1.5 |
| 31 Dec 2021 | FY | -1286.4% | -1672.3% | -121.6% | -72.7% | 0.10 | 3.64 | -4.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -66.3% | -52.1% | 0.03 | 6.31 | -4.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -100.1% | -84.8% | 0.05 | 7.43 | -2.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -680.8% | -588.8% | 0.00 | 8.04 | -0.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -671.8% | -548.7% | 0.00 | 6.23 | -0.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -311.5% | -299.5% | 0.00 | 26.93 | -0.5 |
| -16.7 |
| 30 Sept 2025 | Q3 | 96.7% | -124.6% | 11.7% | -14.3% | -1.60 | 1.02 | -11.3 |
| 30 Jun 2025 | Q2 | 96.8% | 13.6% | -6.8% | 6.5% | -0.50 | 1.70 | 9.9 |
| 31 Mar 2025 | Q1 | 79.2% | 38.7% | -69.0% | 61.3% | -1.00 | 0.57 | 0.4 |
| 31 Dec 2024 | Q4 | 79.3% | -38.8% | 13.0% | -11.6% | -0.45 | 0.48 | -2.8 |
| 30 Sept 2024 | Q3 | 81.1% | -54.5% | 24.2% | -15.4% | -0.72 | 0.59 | -0.7 |
| 30 Jun 2024 | Q2 | 83.8% | -66.5% | 17.2% | -16.2% | -0.48 | 0.42 | -0.7 |
| 31 Mar 2024 | Q1 | 92.7% | -116.1% | 32.3% | -19.2% | -0.57 | 0.59 | -0.8 |
| 31 Dec 2023 | Q4 | 25.7% | -1421.7% | 60.9% | -36.5% | -0.58 | 0.72 | -0.2 |